المؤلفون: Shuang Qin, Linping Xu, Ming Yi, Shengnan Yu, Kongming Wu, Suxia Luo

المصدر: Molecular Cancer, Vol 18, Iss 1, Pp 1-14 (2019)

مصطلحات موضوعية: Immunotherapy, Immune checkpoint, LAG-3, TIM-3, TIGIT, VISTA, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

وصف الملف: electronic resource

العلاقة: http://link.springer.com/article/10.1186/s12943-019-1091-2Test; https://doaj.org/toc/1476-4598Test

الوصول الحر: https://doaj.org/article/7f6ea285e3834011a1ff496a2f1048a8Test

المؤلفون: Yuejiao Dong, Xuefen Li, Lu Zhang, Qiaoyun Zhu, Chunlei Chen, Jiaqi Bao, Yu Chen

المصدر: BMC Immunology, Vol 20, Iss 1, Pp 1-9 (2019)

مصطلحات موضوعية: CD4+ T cells, Chronic HBV infection, Inhibitory molecules, Programmed death 1 (PD-1), Lymphocyte activation gene-3 (LAG-3), Cytokine, Immunologic diseases. Allergy, RC581-607

وصف الملف: electronic resource

العلاقة: http://link.springer.com/article/10.1186/s12865-019-0309-9Test; https://doaj.org/toc/1471-2172Test

الوصول الحر: https://doaj.org/article/3e5f1448ce1b4e36a71764277c28ced0Test

المؤلفون: Mingfang Zhao, Ruoyu Wang, Heming Li, Wenjing Qian

المصدر: Journal of Hematology & Oncology, Vol 14, Iss 1, Pp 1-17 (2021)
Journal of Hematology & Oncology

مصطلحات موضوعية: Cancer Research, medicine.medical_specialty, Programmed cell death, LAG3, Epithelial-Mesenchymal Transition, medicine.drug_class, Review, Biology, Monoclonal antibody, Antigens, CD, LAG-3, Internal medicine, Neoplasms, medicine, Animals, Humans, Diseases of the blood and blood-forming organs, Epithelial–mesenchymal transition, Molecular Targeted Therapy, Molecular Biology, Immune Checkpoint Inhibitors, FGL1, RC254-282, Hematology, Fibrinogen, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Biomarker, Ligand (biochemistry), Lymphocyte Activation Gene 3 Protein, Immune checkpoint, Oncology, Cancer research, Biomarker (medicine), Immune resistance, Tumor Escape, Immunotherapy, RC633-647.5, Immune checkpoint blockade

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c863141164b6748972c800d80e9c95f0Test
https://doaj.org/article/bde087ed0c634ef7af10c3e368eb935bTest

المؤلفون: Tian Tian, Yashuang Zhao, Hao Huang, Jing Xu, Guiyu Wang, Jinming Fu, Lei Zhang, Ding Zhang, Ying Liu, Hongru Sun, Yuanyuan Zhang

المصدر: Molecular Medicine, Vol 27, Iss 1, Pp 1-10 (2021)
Molecular Medicine

مصطلحات موضوعية: Male, Oncology, Colorectal cancer, Programmed Cell Death 1 Receptor, Biochemistry, Epigenesis, Genetic, Workflow, Risk Factors, Databases, Genetic, Medicine, Genetics (clinical), Aged, 80 and over, DNA methylation, Methylation, Middle Aged, Lymphocyte Activation Gene 3 Protein, Gene Expression Regulation, Neoplastic, Immunosurveillance, CpG site, Molecular Medicine, Female, Disease Susceptibility, PDCD-1, Colorectal Neoplasms, Research Article, Adult, medicine.medical_specialty, RM1-950, QD415-436, Lower risk, Risk Assessment, Peripheral blood leukocyte, Immune system, Antigens, CD, LAG-3, Internal medicine, Biomarkers, Tumor, Genetics, Humans, Molecular Biology, Aged, business.industry, Gene Expression Profiling, Computational Biology, Immune Checkpoint Proteins, medicine.disease, Molecular medicine, Case-Control Studies, CpG Islands, Therapeutics. Pharmacology, Transcriptome, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c7fce0f0a2e1f1bbead13b796ea4a2d1Test
https://doaj.org/article/60cbc5aee2e646e98917e4df8a0c9c49Test

المؤلفون: Ming Yi, Suxia Luo, Shengnan Yu, Linping Xu, Shuang Qin, Kongming Wu

المصدر: Molecular Cancer, Vol 18, Iss 1, Pp 1-14 (2019)
Molecular Cancer

مصطلحات موضوعية: 0301 basic medicine, Cancer Research, medicine.drug_class, TIGIT, T-Lymphocytes, T cell, medicine.medical_treatment, TIM-3, Programmed Cell Death 1 Receptor, VISTA, Review, Lymphocyte Activation, Monoclonal antibody, lcsh:RC254-282, Immunomodulation, 03 medical and health sciences, Antineoplastic Agents, Immunological, 0302 clinical medicine, Immune system, LAG-3, Neoplasms, Biomarkers, Tumor, medicine, Animals, Humans, CTLA-4 Antigen, Molecular Targeted Therapy, BTLA, Clinical Trials as Topic, biology, Immunotherapy, lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Immune checkpoint, Treatment Outcome, 030104 developmental biology, medicine.anatomical_structure, B7-H3, Oncology, CTLA-4, 030220 oncology & carcinogenesis, biology.protein, Cancer research, Molecular Medicine, Antibody

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::62ab764b0272cb7de85bf00ba3474375Test
http://link.springer.com/article/10.1186/s12943-019-1091-2Test

المؤلفون: Adili, Ali, Ghoreishizadeh, Shadi, Shomali, Navid, Hasani, Sadegh Abaei, Sharafi, Faezeh, Alesaeidi, Samira, Kahrizi, Mohammad Saeed

مصطلحات موضوعية: Hepatocellular carcinoma, T-Cells, Blockade, Ctla-4, Immune checkpoint inhibitors, Combination therapy, Acquired-Resistance, Tigit, Antitumor, Tim-3, Lag-3, Tremelimumab, Mechanisms

العلاقة: Cancer Cell International; Diğer; https://hdl.handle.net/11454/77817Test; https://doi.org/10.1186/s12935-022-02682-zTest; Kahrizi, Mohammad saeed/0000-0002-8076-2413; 22

الإتاحة: https://doi.org/10.1186/s12935-022-02682-zTest
https://hdl.handle.net/11454/77817Test

المؤلفون: Sharafi, Faezeh, Hasani, Sadegh Abaei, Alesaeidi, Samira, Kahrizi, Mohammad Saeed, Adili, Ali, Ghoreishizadeh, Shadi, Shomali, Navid

مصطلحات موضوعية: Immune checkpoint inhibitors, Hepatocellular carcinoma, Combination therapy, Acquired-Resistance, T-Cells, Blockade, Ctla-4, Tigit, Antitumor, Tim-3, Lag-3, Tremelimumab, Mechanisms

العلاقة: Cancer Cell International; Diğer; https://doi.org/10.1186/s12935-022-02682-zTest; https://hdl.handle.net/11454/85121Test; 22; WOS:000843527300004; 2-s2.0-85136994397

الإتاحة: https://doi.org/10.1186/s12935-022-02682-zTest
https://hdl.handle.net/11454/85121Test